慢加急性肝衰竭患者发生肺部感染的临床特点及预后分析

摘要/Abstract

摘要： 目的分析HBV相关慢加急性肝衰竭患者发生肺部感染的临床特点及预后的影响因素。方法选取2018年3月至2019年1月就诊于珠海市人民医院的HBV相关慢加急性肝衰竭(HBV-ACLF)患者75例,其中合并肺部感染37例,未合并肺部感染38例。分析两组患者的并发症发生情况,检测胆固醇、血清钠、甲胎蛋白、白蛋白、PTA、C反应蛋白等6项生化指标,Child-Pugh评分评估患者预后,分析生化指标与预后的相关性。结果合并肺部感染组患者凝血功能障碍、上消化道出血、肝性脑病及肝肾综合征的发生分别为9例(24.3%)、12例(32.4%)、10例(27%)和9例(24.3%),高于非合并肺部感染组的1例(2.6%)、2例(5.3%)、2例(5.3%)和1例(2.6%),差异均有统计学意义(均P<0.05),腹水的发生率则差异无统计学意义。血清生化指标结果显示,与未合并肺部感染组患者相比,合并肺部感染的患者的血清胆固醇、血清钠、甲胎蛋白、白蛋白、PTA的表达水平下降,CRP及PCT则明显增高,差异有统计学意义(P<0.05)。未合并肺部感染组Child-Pugh评分为(5.3±0.43)分,合并肺部感染组为(8.6±3.3)分,差异有统计学意义(P<0.01)。Spearman相关性分析结果表明,Child-Pugh评分与CRP及PCT含量呈正相关,与胆固醇、血清钠、甲胎蛋白、白蛋白及PTA呈负相关。结论慢加急性肝衰竭患者发生肺部感染时可加重患者症状,影响患者预后,胆固醇、血清钠、血清白蛋白、C反应蛋白、PTA、甲胎蛋白及PCT可能是影响HBV-ACLF合并肺部感染患者预后的重要因素。

关键词: 慢加急性肝衰竭, 肺部感染, Child-Pugh, 相关性分析

Abstract: Objective To analyze the clinical characteristics and prognostic factors of HBV-related chronic acute liver failure patients with lung infection.Methods A total of 75 HBV-related chronic acute liver failure (HBV-ACLF) patients who were admitted to our hospital from March 2018 to January 2019 were selected and divided into the lung infection group (lung infection, LI) according to whether they had pulmonary infection. ) 37 cases in the group and 38 cases in the no lung infection (NLI) group. Collect and analyze the complications of the two groups of patients, check the six biochemical indicators of cholesterol, serum sodium, alpha-fetoprotein, albumin, PTA, and C-reactive protein in the two groups, use the Child-Pugh score to assess the prognosis of the patients, and analyze the two The correlation between biochemical indicators and prognosis of patients in the group.Results Compared with the NLI group, the incidence of coagulation dysfunction, upper gastrointestinal hemorrhage, hepatic encephalopathy, and hepatorenal syndrome in the LI group increased significantly, and the difference was statistically significant (P<0.05), while the incidence of ascites was higher There is no statistical difference. Serum biochemical index Results showed that compared with patients without lung infection, the expression levels of serum cholesterol, serum sodium, alpha-fetoprotein, albumin, and PTA in patients with lung infection decreased, while CRP and PCT were significantly increased. The difference was statistically significant (P<0.05). The Child-Pugh score Results showed that the average Child-Pugh score of the non-pulmonary infection group was 5.3±0.43 points, and the score of the combined lung infection group was 8.6±3.3 points. There was a significant difference between the two (P<0.01). The Results of Spearman correlation analysis showed that Child-Pugh score was positively correlated with CRP and PCT content, and the correlation was statistically significant (P<0.0001). Child-Pugh scores are negatively correlated with cholesterol, serum sodium, alpha-fetoprotein, albumin and PTA, and the correlations are statistically significant (cholesterol P<0.05, serum sodium, alpha-fetoprotein, albumin and PTAP<0.0001).Conclusion Pulmonary infection in patients with chronic acute liver failure can aggravate the symptoms and affect the prognosis of the patients. The expression of cholesterol, serum sodium, serum albumin, C-reactive protein, PTA, alpha-fetoprotein and PCT may affect the combination of HBV-ACLF An important factor for the prognosis of patients with lung infection.

Key words: acute-on-chronic liver failure, lung infection, Child-Pugh, correlation analysis

董杰, 孙孟颖, 周晓蕾, 杨晴. 慢加急性肝衰竭患者发生肺部感染的临床特点及预后分析[J]. 肝脏, 2022, 27(6): 675-678.

DONG Jie, SUN Meng-ying, ZHOU Xiao-lei, YANG Qing. Clinical features and prognostic analysis of pulmonary infection in patients with acute-on-chronic liver failure[J]. Chinese Hepatolgy, 2022, 27(6): 675-678.

参考文献

[1] Verma N, Dhiman RK, Singh V, et al. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF.Hepatol Int, 2021, 15: 753-765.
[2] Wang ML, Yin XJ, Li XL, et al. Retrospective analysis of the clinical efficacy of n-acetylcysteine in the treatment of hepatitis B virus related acute-on-chronic liver failure.Front Med (Lausanne), 2021, 8: 724224.
[3] Zhang K, Sun HX, Cao HJ, et al. The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis.Stem Cell Res Ther, 2021, 12: 466.
[4] Gao J, Zhang Q, Wu YK, et al. Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis.Sci Rep, 2018, 8: 876.
[5] 中华医学会感染病学分会肝衰竭与人工肝组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊疗指南. 现代医药卫生,2018, 34: 3897-3974.
[6] 唐玉萍.抗结核药物对肺结核合并乙型病毒性肝炎感染患者肝功能的影响.临床合理用药杂志,2015,8(9) : 17-18.
[7] 丁立, 刘曦, 谢冬英. 肝功能衰竭患者合并肺部感染的临床分析. 中华实验和临床感染病杂志:电子版,2013,7(6) :843-845.
[8] Yao XB, Yu HP, Fan GY, et al. Impact of the gut microbiome on the progression of hepatitis B virus related acute-on-chronic liver failure.Front Cell Infect Microbiol, 2021, 11: 573923.
[9] Trebicka J, Bork P, Krag A, et al. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.Nat Rev Gastroenterol Hepatol, 2021, 18: 167-180.
[10] Solé C, Guilly S, Da Silva K, et al. Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: relationship with acute-on-chronic liver failure and prognosis. Gastroenterology, 2021, 160: 206-218.e13.
[11] Kumar D, Pandey G, Bansal D, et al. NMR-based urinary profiling of lactulose/mannitol ratio used to assess the altered intestinal permeability in acute on chronic liver failure (ACLF) patients.Magn Reson Chem, 2017, 55: 289-296.
[12] Kaplan DE, Dai F, Aytaman A, et al. Development and performance of an algorithm to estimate the child-turcotte-pugh score from a National Electronic Healthcare Database.Clin Gastroenterol Hepatol, 2015, 13: 2333-41.e1-6.
[13] Hu JH, Zhang XI, Yu GD, et al. Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosis.BMC Gastroenterol, 2019, 19: 94.
[14] Peng Y, Qi XS, Tang SH, et al. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure.Expert Rev Gastroenterol Hepatol, 2016, 10: 971-80.
[15] 王晓霖, 李玲. HBV 相关慢加急性肝功能衰竭患者诱因及预后影响因素的分析. 肝脏,2016,21(1) : 100.
[16] 赵萍,翟玉峰,张怀宏.血清甲胎蛋白和凝血酶原活动度水平对慢加急性肝衰竭患者预后的预测价值研究.实用肝脏病杂志,2017,20(02):230-231.